Variant #0000167025 (NC_000001.10:g.171076952C>T, NM_001002294.2:c.458C>T (FMO3))
Chromosome |
1 |
Allele |
Unknown |
Affects function (as reported) |
Affects function |
Affects function (by curator) |
Affects function |
Classification method |
- |
Clinical classification |
NA |
DNA change (genomic) (Relative to hg19 / GRCh37) |
g.171076952C>T |
DNA change (hg38) |
g.171107811C>T |
Published as |
- |
ISCN |
- |
DB-ID |
FMO3_000001 See all 6 reported entries |
Variant remarks |
variant expected to influence metabolism of drug (xenobiotic) substrates of FMO3 that undergo N- or S-oxygenation; impaired benzydamine N-oxygenation in compound het with E305X or with S173R |
Reference |
PubMed: Mayatepek 2004 |
ClinVar ID |
- |
dbSNP ID |
rs72549326 |
Origin |
In vitro (cloned) |
Segregation |
- |
Frequency |
- |
Re-site |
- |
VIP |
- |
Methylation |
- |
Average frequency (gnomAD v.2.1.1) |
0.00102 View details |
Owner |
Ornicha Prapapan |
Database submission license |
No license selected |
Created by |
Ornicha Prapapan |
Date created |
2013-02-11 19:15:22 +01:00 (CET) |
Date last edited |
2020-06-05 15:14:37 +02:00 (CEST) |

Variant on transcripts
|
Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.
|